Nicholas Potter

Nicholas Potter joined Epigenomics as director of reimbursement and medical affairs, effective Nov. 1. In his position, he will create the firm's reimbursement strategy for its blood-based menu of methylated cancer detection technologies. Most recently, Potter was at MPLN as laboratory director of molecular diagnostics, CSO, and finally executive vice president of clinical affairs.